Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).

Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2004 Apr 21;43(8):1459-65.

3.

Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22.

PMID:
20185000
4.

Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?

Siu CW, Pong V, Ho HH, Liu S, Lau CP, Li SW, Tse HF.

J Cardiovasc Electrophysiol. 2010 Mar;21(3):231-5. doi: 10.1111/j.1540-8167.2009.01609.x. Epub 2009 Oct 5.

PMID:
19804551
5.

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU; MADIT-II Investigators.

J Am Coll Cardiol. 2006 May 2;47(9):1811-7. Epub 2006 Apr 17.

6.

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.

Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT Jr.

Circulation. 2004 Oct 5;110(14):1885-9. Epub 2004 Sep 27.

7.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.

8.

Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, Case RB; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

Am J Cardiol. 2006 Aug 15;98(4):485-90. Epub 2006 Jun 19.

PMID:
16893702
9.

Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2007 Apr 3;49(13):1427-33. Epub 2007 Mar 21.

10.
11.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1487-91.

PMID:
15950580
12.

Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery.

Bigger JT Jr, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB, Steinman RC, Estes NA 3rd.

Circulation. 1999 Mar 23;99(11):1416-21.

13.

Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.

Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ; MADIT-II Research Group.

J Cardiovasc Electrophysiol. 2007 Aug;18(8):833-8. Epub 2007 May 30.

PMID:
17537209
14.

Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.

Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.

J Cardiovasc Electrophysiol. 2007 Feb;18(2):181-4.

PMID:
17338766
15.

Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.

PMID:
17413310
16.

Cost-effectiveness of implantable cardioverter-defibrillators.

Sanders GD, Hlatky MA, Owens DK.

N Engl J Med. 2005 Oct 6;353(14):1471-80.

17.

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ; DINAMIT Investigators.

N Engl J Med. 2004 Dec 9;351(24):2481-8.

18.

Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction.

Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H; MADIT II Investigators.

J Cardiovasc Electrophysiol. 2005 Dec;16(12):1265-70.

PMID:
16403053
19.

Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II.

Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ.

Ann Noninvasive Electrocardiol. 2005 Oct;10(4):429-35.

PMID:
16255753
20.

Baseline characteristics of patients in the coronary artery bypass graft (CABG) Patch Trial.

Curtis AB, Cannom DS, Bigger JT Jr, DiMarco JP, Estes NA 3rd, Steinman RC, Parides MK.

Am Heart J. 1997 Nov;134(5 Pt 1):787-98.

PMID:
9398090

Supplemental Content

Support Center